Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers
NCT06854783 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2026-02-04
Summary
The purpose of this study is to assess the pharmacokinetics, safety, tolerability and food effect of investigational drug MRX1 in healthy adults.
Conditions
- Pharmacokinetics
Interventions
- DRUG
-
Cannabidiol
Cannabidiol
Sponsors & Collaborators
-
Ananda Pharma plc
collaborator UNKNOWN -
Tiamat Australia Pty Ltd
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-07-14
- Primary Completion
- 2025-10-01
- Completion
- 2025-10-01
Countries
- Australia
Study Locations
More Related Trials
-
Food Effects of Single Oral Dose of 600mg TR-701
NCT00671359 ·Status: COMPLETED ·Phase: PHASE1
-
Crossover Study to Evaluate the PK Effects of Two Different Wafer Administration Protocols.
NCT02857361 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Adult Human Volunteers
NCT01875939 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Examine the Acceptable Taste and to Estimate the Amount of Atazanavir and Cobicistat in the Body When Taken as a Combination Product Versus When Taken as Separate Products at the Same Time
NCT04263350 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Bioavailability of Single Subcutaneous Doses of Methylnaltrexone Versus Intravenous Dose
NCT01367496 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Safety and PK Characteristics in Healthy Volunteers
NCT06355349 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2a MIB-626 vs. Placebo COVID-19
NCT05038488 ·Status: COMPLETED ·Phase: PHASE2
-
This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357
NCT03279978 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging
NCT04946383 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Assess Absolute Bioavailability (ABA) of Mobocertinib (TAK-788) and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of Carbon-14 ([14C])-Mobocertinib in Male Healthy Participants
NCT03811834 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacodynamics of BIIX 1 XX in Healthy Young Male Volunteers
NCT02199873 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic (PK) Characterization of Subcutaneous Tulisokibart (MK-7240-010)
NCT06575595 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study to Evaluate the Effect of Food on Pharmacokinetics of ASTX029
NCT04466514 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Evaluate the Absolute Bioavailability of Cenerimod in Healthy Male Participants
NCT07301723 ·Status: COMPLETED ·Phase: PHASE1
-
MK-6194 Site of Injection Study in Healthy Adult Participants (MK-6194-013)
NCT06649877 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the Blood
NCT06647810 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild and Moderate Hepatic Impairment
NCT01126086 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Pharmacokinetics (PK) of Etrumadenant Tablet and Capsule Formulations in Healthy Adult Participants
NCT05277012 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of RO6889678 and the Combination of RO6889678 With Ritonavir in Healthy Participants
NCT02321384 ·Status: TERMINATED ·Phase: PHASE1
-
Determination of Absorption and Elimination of Lamotrigine-XR
NCT00789113 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Itraconazole on the Pharmacokinetics of BIIB074
NCT02698267 ·Status: COMPLETED ·Phase: PHASE1
-
Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration
NCT01737944 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers
NCT02293148 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Safety, Tolerability, and Pharmacokinetics of CC-92480 Formulations in Healthy Adult Participants
NCT04839809 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioavailability and Pharmacokinetic Study of Subcutaneous and Intravenous RO6811135 in Healthy Volunteers
NCT01802853 ·Status: COMPLETED ·Phase: PHASE1